• Blog
  • Tissue Diagnostics Market Analysis | 2022-2028

    Tissue Diagnostics Market Analysis | 2022-2028

    Tissue Diagnostics Market Analysis | 2022-2028
    Report code - SRHL109 Delivery - 2 Weeks
    Tissue Diagnostics Market Growth, Size, Share, Trend, Forecast, & Industry Analysis: 2 See more...

    Market Insights

    "The tissue diagnostics market is expected to grow from USD 5.56 billion in 2022 to USD 8.23 billion by 2028 at a CAGR of 6.75% during the forecast period of 2022-2028."

    Tissue diagnostic is the process of documenting a specific tissue obtained. It can also be defined as the diagnosis of a specific tissue, including its measurement and description, as well as the observation of any abnormalities that may be present. This procedure aids in determining the patient's health and disease status. Immunohistochemistry (IHC), Hematoxylin and Eosin (H&E), and in-situ hybridization are the three major types of tissue diagnostics, with immunohistochemistry (IHC) being the most popular.

    The high prevalence of cancer and chronic diseases, infrastructure development for cancer diagnosis, and increasing healthcare expenditure coupled with growing health awareness are the major factors driving the growth of the market. In addition, technological advancements in the field of tissue diagnostics and the aging population are further expected to bolster the growth of the market during the forecast period.

    Want to get a free sample? Register Here

    Segment Analysis

    Product Insights

    "The consumables segment is expected to register higher growth during the forecast period."

    Based on the product type, the market is segmented into consumables and instruments. The consumables segment is expected to register higher growth during the forecast period. The growth of the segment is attributed to the cost-effectiveness and ease of use of consumables. Furthermore, the growing number of reagent rental agreements is also one of the major factors driving the growth of the consumables market.

    Technology Insights

    "The immunohistochemistry segment is expected to lead the market over the forecast period."

    Based on the technology type, the market is segmented as immunohistochemistry, in situ hybridization, digital pathology and workflow management, and special staining. The immunohistochemistry segment is expected to lead the market over the forecast period. The increasing number of chronic diseases can be attributed to the segment's growth, where this technology is mostly used in tissue diagnostics.

    Disease Insights

    "Breast cancer is expected to be the dominant disease type during the forecast period."

    Based on the disease type, the market is segmented as breast cancer, gastric cancer, lymphoma, prostate cancer, non-small cell lung cancer, and other diseases. Breast cancer is expected to be the dominant disease type during the forecast period due to its increasing number of cases. In addition, advancements in the field of tissue diagnostics and an increase in investment for the development of products for breast cancer diagnosis are expected to contribute to the growth of the segment during the forecast period.

    Regional Trends

    "North America is expected to be dominant throughout the forecast period."

    In terms of regions, the market is segmented as North America, Europe, Asia-Pacific, and Rest of the world. Among these regions, North America is expected to be dominant throughout the forecast period. The market growth in this region is majorly due to the aging population, the increasing number of cancer cases, and increasing healthcare expenditures. In addition, infrastructure development for hospitals and clinical laboratories is expected to drive the growth of the regional market during the forecast period. Europe and Asia-Pacific are also expected to offer substantial growth opportunities over the forecast period.

    Want to get a free sample? Register Here

    Key Players

    Some of the key players in the tissue diagnostics market are-

    • Abbott Laboratories
    • Abcam plc.
    • Agilent Technologies, Inc.
    • Cancer Genetics Inc.
    • Cell Signaling Technology, Inc.
    • Danaher Corporation
    • F. Hoffmann-La Roche Ltd
    • Merck KGaA
    • Sakura Finetek Japan Co., Ltd.
    • Thermo Fisher Scientific Inc.

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into market dynamics and will enable strategic decision-making for existing market players as well as those willing to enter the market.

    What deliverables will you get in this report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth analysis of the Tissue Diagnostics Market

    How lucrative is the future?

    Market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional and country level historical data and forecasts

    Which are the most attractive market segments?

    Market segment analysis and forecast

    Which are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirement?

    10% free customization

     

    Target Audience

    Here is the list of the group of customers that the market hopes to have the greatest opportunity to convert:

    • Distributors
    • Suppliers
    • Manufacturers
    • Logistics organizations
    • Government bodies

    The tissue diagnostics market is segmented into the following categories:

    By Product Type:

    • Consumables
      • Type Analysis: Antibodies, Kits, Reagents, and Probes
    • Instruments
      • Type Analysis: Slide-Staining Systems, Scanners, Tissue-Processing Systems, and Other Instruments

    By Technology Type:

    • Immunohistochemistry
    • In Situ Hybridization
    • Digital Pathology and Workflow Management
    • Special Staining

    By Disease Type:

    • Breast Cancer
    • Gastric Cancer
    • Lymphoma
    • Prostate Cancer
    • Non-Small Cell Lung Cancer
    • Other Diseases

    By End-User Type:

    • Hospitals
    • Research Laboratories
    • Pharmaceutical Companies
    • Contract Research Organizations
    • Others

    By Region:

    • North America (Country Analysis: the USA, Canada, and Mexico) 
    • Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and Rest of Europe)
    • Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and Rest of Asia-Pacific)
    • Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data. We conducted more than 10 detailed primary interviews with market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

    Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to 3 players)
    • SWOT analysis of key players (up to 3 players)  

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com

    Frequently Asked Questions (FAQs)

    Tissue diagnostic is the process of documenting a specific tissue obtained. It can also be defined as the diagnosis of a specific tissue, including its measurement and description, as well as the observation of any abnormalities that may be present. This procedure aids in determining the patient's health and disease status. Immunohistochemistry (IHC), Hematoxylin and Eosin (H&E), and in-situ hybridization are the three major types of tissue diagnostics, with immunohistochemistry (IHC) being the most popular.

    The tissue diagnostics market is expected to witness an impressive growth of 6.75% CAGR during 2022-2028.

    Abbott Laboratories, Abcam plc., Agilent Technologies, Inc., Cancer Genetics Inc., Cell Signaling Technology, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Merck KGaA, Sakura Finetek Japan Co., Ltd., and Thermo Fisher Scientific Inc are among the key players in the market.

    Tissue diagnostics market size is expected to reach USD 8.23 billion by 2028.

    The immunohistochemistry segment is expected to lead market in the foreseeable future.

    Breast cancer is expected to be the dominant disease type in the market in the coming five years.

    North America is expected to be the dominant region in the market during the forecast period.